12globeM

China Updates: Doubling down on the Dynamic Zero-COVID policy

Macro 5 minutes to read

Summary:  China reasserts its adherence to the Dynamic Zero Covid policy yesterday. The Standing Committee of the Chinese Communist Party calls for national mobilization to fight against COVID-19 and warns against narratives that “doubt, question, or dismiss” the country’s pandemic control measures. Prior reference to minimizing socioeconomic costs of pandemic control is replaced by emphasizing duties and fulfilling basic livelihood.


The Standing Committee of the Chinese Communist Party’s Politburo  (the Standing Committee) doubled down on the Dynamic Zero-COVID policy in a meeting on May 5, 2022.  The meeting, which President Xi Jinping chaired, asserts China’s unswerving adherence to the Dynamic Zero Covid policy.  The Standing Committee commands party cadres, government officials, and community leaders at all levels to unite themselves in thinking and actions close to the centre of the Chinese Communis Party (the Party) and not to waver in pandemic control.  In the view of the Standing Committee, China’s pandemic control policy is a matter of the nature  and principle of the Party. 

Resemblance of war-time mobilization. The Standing Committee urges party cadres and government officials to speed up and extend the scope of pandemic control measures and tighten control and coordination.  It is worth to note that the remark by the Standing Committee on a prior meeting on March 17, 2022 that “more effective measures should be taken to achieve maximum effect in prevention and control with minimum cost, and to reduce the impact on socioeconomic development as much as possible” is missing this time and replaced by the bare minimum reference to “protecting people’s basic livelihood and supplies of daily necessities and their need for medical care”.  society against the Dynamic Zero Covid policy. 

The Standing Committee calls on comprehensive mobilization throughout the party, the government and the society to earnestly enforce pandemic control.  It emphasizes that it is a duty of not only party cadres and government officials but also industries, corporate and individuals to do their parts well in the war against the pandemic. Throughout the press release, the tone resembles a war time mobilisation which calls for unity, determination, and sacrifices. In other words, the economic costs and the risk of sharply lower economic growth are all secondary to the priority of the Dynamic Zero-COVID policy. 

Putting down the pushback against Dynamic Zero-COVID policy.  The Standing Committee urges party cadres and government officials to overcome “inadequate understanding, lacking preparedness, insufficient work, complacency, indifference, self-righteousness, feeling of exhaustion, tiring of fighting, leaving things to luck and sloppiness”.  It vows to fight against narratives that “distort, question, or dismiss” China’s Dynamic Zero-COVID policy.  This warning seems aiming at putting down the emergent voice of discontents from some corners of the society, including some from social elites, against the lockdowns and other stringent controlling measures. 

Stimulus initiatives are pushing on a string. Relaxation of Dynamic Zero-COVID policy is now completely off-the-table.  The Standing Committee’s decision and subsequent statement puts an end to the any emergent debate in the society or even among certain ranks and files of the government about the enormous costs of persistent and pervasive pandemic control measures.  This is going to have enormous negative impact on the economy and the financial markets.  The much talked about economic, fiscal and monetary stimulus policy initiatives, even having been rolled out, will be just pushing on a string.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.